UK markets closed
  • FTSE 100

    7,018.60
    -140.92 (-1.97%)
     
  • FTSE 250

    17,972.69
    -359.00 (-1.96%)
     
  • AIM

    833.59
    -13.83 (-1.63%)
     
  • GBP/EUR

    1.1189
    -0.0251 (-2.19%)
     
  • GBP/USD

    1.0857
    -0.0398 (-3.54%)
     
  • BTC-GBP

    17,495.61
    -151.32 (-0.86%)
     
  • CMC Crypto 200

    434.61
    -9.92 (-2.23%)
     
  • S&P 500

    3,693.23
    -64.76 (-1.72%)
     
  • DOW

    29,590.41
    -486.27 (-1.62%)
     
  • CRUDE OIL

    79.43
    -4.06 (-4.86%)
     
  • GOLD FUTURES

    1,651.70
    -29.40 (-1.75%)
     
  • NIKKEI 225

    27,153.83
    -159.30 (-0.58%)
     
  • HANG SENG

    17,933.27
    -214.68 (-1.18%)
     
  • DAX

    12,284.19
    -247.44 (-1.97%)
     
  • CAC 40

    5,783.41
    -135.09 (-2.28%)
     

bonyf NV: 25% increase in turnover in H1 2022

·3-min read

bonyf NV
bonyf NV: 25% increase in turnover in H1 2022

14-Sep-2022 / 18:00 CET/CEST
Dissemination of a French Regulatory News, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.

25% increase in turnover in H1 2022
Continued commercial efforts to attain new customers

Ghent (Belgium), 14 September 2022, 6:00 p.m.; bonyf NV (Mnemonic: MLBON), the next-generation oral comfort expert, announces a strong growth in turnover for the first half of 2022 compared to the first half of 2021.

In K
Unaudited data

06/2022

06/2021

Variation

Turnover

1,406

1,123

+25.2%


The 2021 financial year showed a comparative growth of 14% for bonyf.  This trend has accelerated in the first half of 2022 with invoicing of 1,406K, ie. an increase of 25%.
bonyf benefited from the favourable sales trend of its OlivaFix range of denture adhesive creams, which grew by more than 37% to 250K over the H1 period. Containing 30% olive oil, the OlivaFix range of adhesive creams are safer than most denture adhesive creams found on the market, which contain a variety of petrochemicals. One of the most common ingredients in denture adhesive creams is petrolatum, also known as vaseline/petroleum jelly, a potential carcinogenic, according to the office ECHA website
(https://echa.europa.eu/fr/substance-information/-/substanceinfo/100.029.428)
bonyf appointed Mr Ben Mettepenningen as International Business Manager to support its growth trajectory resulting in promising prospects in several countries.
The company will continue its business development policy based on the launch of new innovative products and the acquisition of strategic customers.
While taking into account the adverse effects of inflation, bonyf confirms its objective of achieving a strong growth in turnover.

bonyf’s strengths

  • Products with patented formulations

  • Produced in Switzerland compliant with stringent international quality regulations

  • Proven clinical efficacy

  • Commercial presence in 37 countries

  • Prospects for solid growth and rapid profitability

  • A fast-growing oral and dental care market

About bonyf
Incorporated in 1979, bonyf specialises in the development, production and selling of cutting-edge oral & dental care products. Through its unwavering commitment to innovation and continuous improvement, bonyf makes a real difference to people suffering from dental and oral conditions. The company has its R&D facilities in Liechtenstein (in the renown dental valley), a production plant in Switzerland and distributes its product range in 37 countries worldwide. Benefiting from seven patent protected formulations and products developed in-house, bonyf expects strong future development, driven by the fast-growing oral and dental care market.
Learn more at https://bonyf.com

bonyf
Jean-Pierre Bogaert
investor@bonyf.com

Press Relations
CapValue
info@capvalue.fr
+33 1 80 81 50 00

Regulatory filing PDF file

File: bonyf PR S1 Revenue 2022


Language:

English

Company:

bonyf NV

Doornzelestraat 114 D

9000 Gent

Belgium

Phone:

+41 79 412 42 79

E-mail:

president@bonyf.com

Internet:

www.bonyf.com

ISIN:

BE6333353298

Euronext Ticker:

MLBON

AMF Category:

Inside information / Other releases

EQS News ID:

1442717

 

End of Announcement

EQS News Service

show this
show this